FDA Inspection 967430 — Chinese Peptide Company
The FDA completed an inspection of Chinese Peptide Company on Mar 17, 2016 in Hangzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 17, 2016
- Fiscal Year
- 2016
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Hangzhou (China)